Oseltamivir Phosphate For Oral Suspension Powder, For Suspension
Product Images NDC 72516-029

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate For Oral Suspension (NDC 72516-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL powder for suspension. The label includes preparation instructions, storage conditions, and notes for pharmacists and patients. It mentions the usable volume of 60 mL after constitution and is manufactured for Oryza Pharmaceuticals Inc., Coral Springs, FL.*

FDA Label Image

Label (Label)

Label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL powder for suspension, available in a 60 mL usable volume after constitution. The label states oral route and emphasizes shaking well before each use. It includes preparation instructions for pharmacists and storage directions. Manufactured for Oryza Pharmaceuticals Inc.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Oseltamivir Phosphate, showing its molecular framework with labeled carbon atoms and functional groups including ester, amine, and phosphate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.